Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism
- 1 July 1996
- journal article
- Published by Springer Nature in Psychopharmacology
- Vol. 126 (2), 125-131
- https://doi.org/10.1007/bf02246347
Abstract
The purpose of the present study was to investigate whether the cannabinoid and cholinergic systems impair working memory through a common mechanism. This hypothesis was tested by examining whether the cannabinoid antagonist SR141716A would ameliorate radial-arm performance deficits caused by either the naturally occurring cannabinoid, Δ9-THC, or scopolamine, a muscarinic antagonist. In addition, we evaluated whether the cholinesterase inhibitor, physostigmine, would prevent Δ9-THC-induced impairment of spatial memory. Finally, because the locomotor suppressive effects of cannabinoids may decrease radial arm choice accuracy independent of a direct effect on memory, we examined the impact of increasing the intertrial error on radial arm choice accuracy. As previously reported, Δ9-THC impaired maze performance (ED50=3.0 mg/kg). Increasing the intertrial interval from 5 s to 30 s resulted in a three-fold increase in the amount of time required to complete the maze without affecting choice accuracy. Importantly, SR141716A prevented Δ9-THC-induced deficits in radial-arm choice accuracy in a dose-dependent manner (AD50=2.4 mg/kg); however, the cannabinoid antagonist failed to improve the disruptive effects of scopolamine. Conversely, physostigmine failed to improve performance deficits produced by Δ9-THC. These data provide strong evidence that Δ9-THC impairs working memory through direct action at cannabinoid receptors. Moreover, these results suggest that scopolamine and Δ9-THC do not impair spatial memory in a common serial pathway, though they may converge on a third neurochemical system.Keywords
This publication has 41 references indexed in Scilit:
- Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in ratsNeuropharmacology, 1995
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Reversible effects of acute and long-term administration of Δ-9-tetrahydrocannabinol (THC) on memory in the ratDrug and Alcohol Dependence, 1991
- Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performancePharmacology Biochemistry and Behavior, 1991
- Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in miceNeuropharmacology, 1991
- Lack of Tolerance to Δ 9 -Tetrahydrocannabinol in ChimpanzeesScience, 1973
- Retrieval of Information after Use of MarihuanaNature, 1971
- Effects of (–) ▵9-trans-Tetrahydrocannabinol and a Synthetic Derivative on Maze Performance of RatsPharmacology, 1970